Tag:
Somanetics
Latest Headlines
Latest Headlines
Shareholders seek to block ev3 sale
ev3 ( NASDAQ:EVVV ) and its directors are facing several shareholder lawsuits designed to block the sale of the company to Covidien ( NYSE:COV ). The companies announced earlier this month that Covidien
Covidien buys Somanetics for $250M
Ireland's Covidien ( NYSE: COV ) announced that it will acquire all outstanding shares of Somanetics for $25 per share in cash, in a deal worth $250 million. The moved is part of Covidien strategy to
